An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements. In the treatment of newly diagnosed biliary tract cancer, the current standard ...

Sydney Towle, 26, has documented her journey with rare, aggressive bile duct cancer since she was diagnosed in 2023 ...

When do you have tests for bile duct cancer? Bile duct cancer is also called cholangiocarcinoma. It is a rare type of cancer that develops in the bile ducts. Most people are diagnosed with bile duct ...

The FDA on Wednesday granted accelerated approval to zanidatamab (Ziihera), a bispecific antibody, for pretreated HER2-positive biliary tract cancer. Approval stipulates use in unresectable or ...

Zanidatamab continued to lead to responses and improved overall survival in pretreated HER2-positive biliary tract cancer. Zanidatamab continued to be efficacious in treating patients with previously ...

Adding liposome-encapsulated irinotecan to standard chemotherapy failed to improve survival as second-line treatment for advanced biliary cancer, a small randomized study showed. Median ...

Gallbladder cancer and cholangiocarcinoma are different types of biliary tract cancer. They affect the same system in the body and cause similar symptoms, but they may require different treatments.

Rachna Shroff, MD, is the associate director of clinical investigations at the U of A Cancer Center and a professor and chief of the division of hematology and oncology at the College of Medicine – ...

People who take low-dose aspirin have a significantly lower risk of developing bile duct cancer than nonusers, new research shows. The findings add to the already substantial evidence that aspirin has ...

Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...